Brief: Amylyx Pharmaceuticals Q2 EPS USD -1.07
08/08/2024 12:00
Aug 08 (Reuters) - Amylyx Pharmaceuticals Q2 operating income USD -76.286 million. * Q2 net income USD -72.7 million * Q2 operating expenses USD 75.263 million * Q2 pretax profit USD -72.7 million * Q2 cash & investments USD 309.8 million
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock